Long non-coding RNA CCAT1 promotes gallbladder cancer development via negative modulation of miRNA-218-5p

Cell Death and Disease

Volumn 6, Issue 1, 2015, Pages

  Ma, M Z ^a,b   Chu, B F ^a   Zhang, Y ^c   Weng, M Z ^a   Qin, Y Y ^a   Gong, W ^a   Quan, Z W ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

^b YANGZHOU UNIVERSITY   (China)

^c WANNAN MEDICAL COLLEGE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BMI1 PROTEIN; COLON CANCER ASSOCIATED TRANSCRIPT 1 PROTEIN; LONG UNTRANSLATED RNA; MESSENGER RNA; MICRORNA; MICRORNA 218 5P; ONCOPROTEIN; UNCLASSIFIED DRUG; BMI1 PROTEIN, HUMAN; CCAT1 LONG NONCODING RNA, HUMAN; MIRN218 MICRORNA, HUMAN;

ANIMAL MODEL; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; FEMALE; GALLBLADDER CARCINOMA; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; GENE SILENCING; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; MOLECULAR PATHOLOGY; MOUSE; NONHUMAN; PRIORITY JOURNAL; TRANSCRIPTION REGULATION; TUMOR INVASION; TUMOR XENOGRAFT; UPREGULATION; CARCINOGENESIS; GALLBLADDER TUMOR; GENETICS; METABOLISM; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; PATHOLOGY; TUMOR CELL LINE;

BASE SEQUENCE; CARCINOGENESIS; CELL LINE, TUMOR; CELL PROLIFERATION; GALLBLADDER NEOPLASMS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICRORNAS; MOLECULAR SEQUENCE DATA; NEOPLASM INVASIVENESS; POLYCOMB REPRESSIVE COMPLEX 1; RNA, LONG NONCODING; UP-REGULATION;

EID: 84927629286     PISSN: None     EISSN: 20414889     Source Type: Journal    
DOI: 10.1038/cddis.2014.541     Document Type: Article

References (34)

1. Zhu AX, Hong TS, Hezel AF, Kooby DA. Current management of gallbladder carcinoma. Oncologist 2010; 15: 168-181.
2. Jiao Y, Pawlik TM, Anders RA, Selaru FM, Streppel MM, Lucas DJ et al. Exome sequencing identifies frequent inactivating mutations in BAP1, ARID1A and PBRM1 in intrahepatic cholangiocarcinomas. Nat Genet 2013; 45: 1470-1473.
3. Ooi A, Suzuki S, Nakazawa K, Itakura J, Imoto I, Nakamura H et al. Gene amplification of Myc and its coamplification with ERBB2 and EGFR in gallbladder adenocarcinoma. Anticancer Res 2009; 29: 19-26.
4. Shi X, Sun M, Liu H, Yao Y, Song Y. Long non-coding RNAs: a new frontier in the study of human diseases. Cancer Lett 2013; 339: 159-166.
5. Peng HH, Zhang YD, Gong LS, Liu WD, Zhang Y. Increased expression of microRNA-335 predicts a favorable prognosis in primary gallbladder carcinoma. Onco Targets Ther 2013; 6: 1625-1630.
6. Yeh YM, Chuang CM, Chao KC, Wang LH. MicroRNA-138 suppresses ovarian cancer cell invasion and metastasis by targeting SOX4 and HIF-1α. Int J Cancer 2013; 133: 867-878.
7. Kono H, Nakamura M, Ohtsuka T, Nagayoshi Y, Mori Y, Takahata S et al. High expression of microRNA-155 is associated with the aggressive malignant behavior of gallbladder carcinoma. Oncol Rep 2013; 30: 17-24.
8. Yang F, Xue X, Bi J, Zheng L, Zhi K, Gu Y et al. Long noncoding RNA CCAT1, which could be activated by c-Myc, promotes the progression of gastric carcinoma. J Cancer Res Clin Oncol 2013; 139: 437-445.
9. Zhang EB, Yin DD, Sun M, Kong R, Liu XH, You LH et al. P53-regulated long non-coding RNA TUG1 affects cell proliferation in human non-small cell lung cancer, partly through epigenetically regulating HOXB7 expression. Cell Death Dis 2014; 5: e1243.
10. Yang F, Huo XS, Yuan SX, Zhang L, Zhou WP, Wang F et al. Repression of the long noncoding RNA-LET by histone deacetylase 3 contributes to hypoxia-mediated metastasis. Mol Cell 2013; 49: 1083-1096.
11. Liu Q, Huang J, Zhou N, Zhang Z, Zhang A, Lu Z et al. LncRNA loc285194 is a p53-regulated tumor suppressor. Nuclei Acids Res 2013; 41: 4976-4987.
12. Zhang Z, Zhu Z, Watabe K, Zhang X, Bai C, Xu M et al. Negative regulation of lncRNA GAS5 by miR-21. Cell Death Differ 2013; 20: 1558-1568.
13. Jalali S, Bhartiya D, Lalwani MK, Sivasubbu S, Scaria V. Systematic transcriptome wide analysis of lncRNA-miRNA interactions. PLoS One 2013; 8: e53823.
14. Juan L, Wang G, Radovich M, Schneider BP, Clare SE, Wang Y et al. Potential roles of microRNAs in regulating long intergenic noncoding RNAs. BMC Med Genomics 2013; 6 (Suppl 1): S7.
15. Nissan A, Stojadinovic A, Mitrani-Rosenbaum S, Halle D, Grinbaum R, Roistacher M et al. Colon cancer associated transcript-1: a novel RNA expressed in malignant and premalignant human tissues. Int J Cancer 2012; 130: 1598-1606.
16. Karreth FA, Pandolfi PP. ceRNA cross-talk in cancer: when ce-bling rivalries go awry. Cancer Discov 2013; 3: 1113-1121.
17. Huang JF, Guo YJ, Zhao CX, Yuan SX, Wang Y, Tang GN et al. Hepatitis B virus X protein (HBx)-related long noncoding RNA (lncRNA) down-regulated expression by HBx (Dreh) inhibits hepatocellular carcinoma metastasis by targeting the intermediate filament protein vimentin. Hepatology 2013; 57: 1882-1892.
18. Li JH, Liu S, Zhou H, Qu LH, Yang JH. starBase v2.0: decoding miRNA-ceRNA, miRNAncRNA and protein-RNA interaction networks from large-scale CLIP-Seq data. Nucleic Acids Res 2014; 42(Database issue): D92-D97.
19. Wang K, Sun T, Li N, Wang Y, Wang JX, Zhou LY et al. MDRL lncRNA regulates the processing of miR-484 primary transcript by targeting miR-361. PLoS Genet 2014; 10: e1004467.
20. Carthew RW, Sontheimer EJ. Origins and mechanisms of miRNAs and siRNAs. Cell 2009; 136: 642-655.
21. Gregory RI, Chendrimada TP, Cooch N, Shiekhattar R. Human RISC couples microRNA biogenesis and posttranscriptional gene silencing. Cell 2005; 123: 631-640.
22. Karginov FV, Conaco C, Xuan Z, Schmidt BH, Parker JS, Mandel G et al. A biochemical approach to identifying microRNA targets. Proc Natl Acad Sci USA 2007; 104: 19291-19296.
23. Kam Y, Rubinstein A, Naik S, Djavsarov I, Halle D, Ariel I et al. Detection of a long non-coding RNA (CCAT1) in living cells and human adenocarcinoma of colon tissues using FIT-PNA molecular beacons. Cancer Lett 2014; 352: 90-96.
24. Mathew LK, Skuli N, Mucaj V, Lee SS, Zinn PO, Sathyan P et al. miR-218 opposes a critical RTK-HIF pathway in mesenchymal glioblastoma. Proc Natl Acad Sci USA 2014; 111: 291-296.
25. Zhu Z, Xu Y, Du J, Tan J, Jiao H. Expression of microRNA-218 in human pancreatic ductal adenocarcinoma and its correlation with tumor progression and patient survival. J Surg Oncol 2014; 109: 89-94.
26. Yamasaki T, Seki N, Yoshino H, Itesako T, Hidaka H, Yamada Y et al. MicroRNA-218 inhibits cell migration and invasion in renal cell carcinoma through targeting caveolin-2 involved in focal adhesion pathway. J Urol 2013; 190: 1059-1068.
27. Tu Y, Gao X, Li G, Fu H, Cui D, Liu H et al. MicroRNA-218 inhibits glioma invasion, migration, proliferation, and cancer stem-like cell self-renewal by targeting the polycomb group gene Bmi1. Cancer Res 2013; 73: 6046-6055.
28. Salmena L, Poliseno L, Tay Y, Kats L, Pandolfi PP. A ceRNA hypothesis: the Rosetta Stone of a hidden RNA language? Cell 2011; 146: 353-358.
29. Wang J, Liu X, Wu H, Ni P, Gu Z, Qiao Y et al. CREB up-regulates long non-coding RNA, HULC expression through interaction with microRNA-372 in liver cancer. Nucleic Acids Res 2010; 38: 5366-5383.
30. Kallen AN, Zhou XB, Xu J, Qiao C, Ma J, Yan L et al. The imprinted H19 lncRNA antagonizes let-7 microRNAs. Mol Cell 2013; 52: 101-112.
31. Han Y, Liu Y, Zhang H, Wang T, Diao R, Jiang Z et al. Hsa-miR-125b suppresses bladder cancer development by down-regulating oncogene SIRT7 and oncogenic long non-coding RNA MALAT1. FEBS Lett 2013; 587: 3875-3882.
32. Cesana M, Cacchiarelli D, Legnini I, Santini T, Sthandier O, Chinappi M et al. A long noncoding RNA controls muscle differentiation by functioning as a competing endogenous RNA. Cell 2011; 147: 358-369.
33. Wang K, Liu F, Zhou LY, Long B, Yuan SM, Wang Y et al. The long noncoding RNA CHRF regulates cardiac hypertrophy by targeting miR-489. Circ Res 2014; 114: 1377-1388.
34. Wang JH, Li LF, Yu Y, Li B, Jin HJ, Shen DH et al. Establishment and characterization of a cell line, EH-GB2, derived from hepatic metastasis of gallbladder cancer. Oncol Rep 2012; 27: 775-782.